Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00073931 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: sargramostim
PROCEDURE: autologous bone marrow transplantation
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: tositumomab and iodine I 131 tositumomab

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]